ADVANCE PURCHASE AGREEMENT FOR SARS-CoV-2/COVID-19 VACCINE
Procurement of Janssen's vaccine candidate Ad26.COV2-S.
Buyer
Business Energy and Industrial Strategy
Value
£1
Published
12 Feb 2021
Closes
12 Feb 2021
Procurement details
Source
Find a Tender
Region
United Kingdom
Procurement method
Limited
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33651600
Vaccines
Lots
Lot 1 ADVANCE PURCHASE AGREEMENT FOR SARS-CoV-2/COVID-19 VACCINE
£1
This contract has been procured using the negotiated procedure without prior publication under regulation 32 of the Public Contracts Regulations 2015 on the basis that the award of the contract to Janssen is strictly necessary for unforeseeable reasons of extreme urgency; i.e. the urgent requirement to secure priority access to a viable vaccine to end the Co...
Delivery: Belgique-België
Documents
No document metadata is available for this public record.
Contains public sector information licensed under the Open Government Licence v3.0.